Care Gaps in Sodium-Glucose Cotransporter-2 Inhibitor and Renin Angiotensin System Inhibitor Prescriptions for Patients with Diabetic Kidney Disease

BACKGROUND: Renin and angiotensin system inhibitors (RAASi) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) are recommended for patients with diabetic kidney disease (DKD) to reduce the progression to end-stage kidney disease; however, they are under-prescribed. OBJECTIVE: To evaluate the fre...

Descripción completa

Detalles Bibliográficos
Autores principales: Rikin, Sharon, Deccy, Stephanie, Zhang, Chenshu, Crandall, Jill, Deng, Yuting, Golestaneh, Ladan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212863/
https://www.ncbi.nlm.nih.gov/pubmed/36352203
http://dx.doi.org/10.1007/s11606-022-07863-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212863/
https://www.ncbi.nlm.nih.gov/pubmed/36352203
http://dx.doi.org/10.1007/s11606-022-07863-0

Ejemplares similares